paroxetine

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Paxil
gptkbp:activities gptkb:drug
gptkbp:approves gptkb:1992
gptkb:FDA
gptkbp:brand gptkb:Seroxat
gptkb:Paxil
gptkbp:class SSRI
gptkbp:clinical_trial efficacy studies
safety studies
gptkbp:contraindication pregnancy
breastfeeding
MAO inhibitors
gptkbp:dosage_form 60 mg daily
20 mg daily
40 mg daily
gptkbp:duration several weeks
long-term use possible
https://www.w3.org/2000/01/rdf-schema#label paroxetine
gptkbp:ingredients C19 H20 FN O3 S
gptkbp:interacts_with gptkb:beer
other antidepressants
NSAI Ds
gptkbp:is_available_in generic form
gptkbp:is_available_on gptkb:tablet
oral suspension
gptkbp:is_used_for gptkb:post-traumatic_stress_disorder
anxiety disorders
obsessive-compulsive disorder
major depressive disorder
panic disorder
gptkbp:lifespan 21 hours
gptkbp:marketed_as gptkb:Glaxo_Smith_Kline
gptkbp:metabolism liver
gptkbp:products gptkb:citalopram
gptkb:escitalopram
fluoxetine
sertraline
gptkbp:research_areas gptkb:historical_event
anxiety
PTSD
OCD
gptkbp:side_effect nausea
drowsiness
insomnia
dry mouth
weight gain
sexual dysfunction
gptkbp:symptoms dizziness
nausea
irritability
sensory disturbances
gptkbp:type_of 61869-08-7
gptkbp:was_marked_by Paxil CR
Paxil XR